Avalon Trust Co bought a new position in shares of STERIS plc (NYSE:STE – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 144 shares of the medical equipment provider’s stock, valued at approximately $30,000.
A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Hilton Capital Management LLC raised its stake in shares of STERIS by 4.5% during the fourth quarter. Hilton Capital Management LLC now owns 6,887 shares of the medical equipment provider’s stock worth $1,416,000 after buying an additional 297 shares during the last quarter. LBP AM SA grew its holdings in STERIS by 151.3% during the 4th quarter. LBP AM SA now owns 26,519 shares of the medical equipment provider’s stock worth $5,451,000 after acquiring an additional 15,965 shares during the period. EverSource Wealth Advisors LLC raised its position in shares of STERIS by 41.9% during the 4th quarter. EverSource Wealth Advisors LLC now owns 1,117 shares of the medical equipment provider’s stock valued at $230,000 after acquiring an additional 330 shares during the last quarter. Natural Investments LLC acquired a new position in shares of STERIS in the 4th quarter valued at $334,000. Finally, Citizens Financial Group Inc. RI boosted its position in shares of STERIS by 5.9% in the 4th quarter. Citizens Financial Group Inc. RI now owns 975 shares of the medical equipment provider’s stock worth $201,000 after purchasing an additional 54 shares during the last quarter. Institutional investors own 94.69% of the company’s stock.
Analyst Ratings Changes
STE has been the subject of a number of recent analyst reports. Piper Sandler upped their price objective on STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a report on Monday, February 3rd. Stephens reiterated an “overweight” rating and issued a $240.00 price target on shares of STERIS in a research report on Thursday, February 6th. Finally, JMP Securities restated a “market outperform” rating and set a $265.00 price objective on shares of STERIS in a report on Thursday, February 6th. One analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $258.75.
STERIS Trading Up 2.1 %
NYSE STE opened at $227.04 on Monday. STERIS plc has a one year low of $197.82 and a one year high of $248.24. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.13 and a quick ratio of 1.40. The firm has a market cap of $22.31 billion, a P/E ratio of 48.20 and a beta of 0.92. The stock’s 50-day moving average is $219.17 and its 200-day moving average is $222.38.
STERIS (NYSE:STE – Get Free Report) last announced its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. Sell-side analysts anticipate that STERIS plc will post 9.08 earnings per share for the current fiscal year.
STERIS Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, March 21st. Investors of record on Thursday, February 20th will be paid a $0.57 dividend. This represents a $2.28 dividend on an annualized basis and a yield of 1.00%. The ex-dividend date is Thursday, February 20th. STERIS’s payout ratio is presently 48.41%.
About STERIS
STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.
Featured Articles
- Five stocks we like better than STERIS
- 3 Stocks to Consider Buying in October
- How to Build the Ultimate Everything ETF Portfolio
- How to Start Investing in Real Estate
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- How to Invest in Blue Chip Stocks
- 3 Stocks With High ROE and Market-Beating Growth Potential
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STE – Free Report).
Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.